Ghrelin - A Possible Opportunity to Improve Appetite, Nutritional State, Metabolic Integrity and Physical Functioning in Cancer Patients With Progressive Weight Loss
Randomized study with follow up evaluations each month until preterminal state. Cancer
patients will be randomised to either high dose or low dose of active treatment given as
daily injection.
Interventional
Allocation: Randomized, Endpoint Classification: Efficacy Study, Intervention Model: Parallel Assignment, Masking: Double Blind (Subject, Caregiver, Investigator), Primary Purpose: Treatment
Food intake
June 2008
No
Kent Lundholm, MD, prof
Principal Investigator
Göteborg University
Sweden: Medical Products Agency
kl4501123
NCT00681486
October 2003
July 2008
Name | Location |
---|